Prestige Consumer Healthcare to Announce Q2 Earnings
Excitement is building as Prestige Consumer Healthcare Inc. (NYSE: PBH) prepares to unveil its fiscal 2025 second quarter earnings results. Scheduled for release on Thursday, November 7, 2024, the announcement will come before the market opens. This is an eagerly awaited event for investors and stakeholders alike.
Conference Call Scheduled
Following the earnings release, the company will conduct a conference call that morning at 8:30 a.m. ET to discuss the results thoroughly. This conference call provides a significant opportunity for analysts and investors to gain insights directly from company executives.
How to Join the Conference Call
Those interested in participating in the live conference call can access it through the Investor Relations page of Prestige Consumer Healthcare. It is advisable for participants to register for the call in advance to receive the necessary dial-in details and unique pin. Joining the call 10 minutes early is recommended, ensuring a seamless experience.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare is known for its vast portfolio of consumer health products, which it markets, sells, and distributes across various regions, including the U.S., Canada, and Australia. Their well-established brands include Monistat, Summer's Eve, BC, Goody's, Clear Eyes, and many others. Each product line addresses specific health needs, ensuring that the company plays a vital role in the marketplace.
Diverse Product Range
The company's diverse product offerings range from women's health solutions to pediatric care, including notable items like Dramamine for motion sickness, Fleet enemas, and Gaviscon in Canada. Their targeted approach to consumer needs allows them to maintain a strong presence in the healthcare industry.
Future Outlook for Prestige Consumer Healthcare
As the company approaches its earnings announcement, there is great anticipation regarding the financial performance of Prestige Consumer Healthcare. With a focus on innovation and consumer satisfaction, the company is well-positioned for growth in an increasingly competitive landscape.
Investor Relations Contact
For further inquiries, investors can reach out directly to Phil Terpolilli, CFA, at 914-524-6819 or via email at irinquiries@prestigebrands.com. This open line of communication underscores the company’s commitment to maintaining transparency and fostering trust with its stakeholders.
Frequently Asked Questions
When will Prestige Consumer Healthcare's Q2 earnings be released?
The earnings results will be announced on November 7, 2024, before the market opens.
What time is the conference call?
The conference call will take place at 8:30 a.m. ET on the same day as the earnings release.
How can I access the conference call?
Investors can join the call through the Investor Relations page of Prestige Consumer Healthcare. Pre-registration is recommended.
What products does Prestige Consumer Healthcare offer?
The company offers a wide range of consumer health products including pain relievers, women's health products, and eye care items among others.
Who can I contact for more information?
Investors can reach Phil Terpolilli at 914-524-6819 or email irinquiries@prestigebrands.com for further information.
